Research

The CPM develop and implement key technology for proteomics, glycomics and metabolomics research at the LUMC. This includes mass spectrometry (MS) hyphenated to liquid chromatography, capillary electrophoresis, and gas chromatography, as well as nuclear magnetic resonance (NMR). The CPM is organized in the 5 research groups proteomics, glycomics, metabolomics, bioinformatics and mass spectrometry imaging. Our facilities and offices are located in the main building of the Leiden University Medical Center. Our collaborations with academic partners and industry cover biological, biomedical, pharmaceutical and clinical research. We train bachelor, master and PhD students as well as international visitors.

Groups

Proteomics

The proteomics group performs state-of-the art mass spectrometric analyses of peptides/proteins, with an historical focus on immunology, i.e. HLA-peptidomics, cell biology and microbiology.
Glycomics

Glycosylation plays important roles in immunity, development, infectious diseases and cancer.
Metabolomics

Metabolomics is defined as the systemic analysis of the metabolome, which encompasses the totality of the metabolites in a biological system, i.e., the end-points and intermediate products of metabolism
MS Imaging

Mass spectrometry imaging (MSI) is a technology that simultaneously provides the spatial distribution of hundreds of biomolecules directly from tissue.
Bioinformatics

The Bioinformatics group uses computational tools to bring together data from different domains in order to better understand human disease.
Tissue Glycomics

The Tissue Glycomics group is dedicated to study glycosylation in human tissues in health and disease.

News

Thesis defense Wei Wang

March 14, 2024
EFSD/Lilly Europese subsidie (100.000 euro) voor diabetesonderzoek toegekend aan Bruno Guigas (LUCID)

March 14, 2024
Prof. Ugur Sahin visits CPM

January 25, 2024